Healthy Skepticism Library item: 607

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Manson JE, Faich GA.
Conflicts of interest--editorialists respond.
N Engl J Med 1996 Oct 3; 335:(14):1064-5

Keywords:
*letter to the editor United States Servier Interneuron Pharmaceutical dexfenfluramine conflict of interest obesity relationship between researchers, academic institutions and industry ETHICAL ISSUES IN PROMOTION: LINKS BETWEEN HEALTH PROFESSIONALS AND INDUSTRY

Notes:

The authors wrote an editorial to accompany an article about safety and efficacy of the weight reduction drug dexfenfluramine. After the editorial was written, it was learned that the editorialists had had dealings with Interneuron Pharmaceutical (the U.S. sponsor of the drug) and Servier (the European manufacturer). In this letter the authors explain their position on this possible conflict of interest.